Resources Hub
Ashpalion 25 years logo

SPIOMET4HEALTH project | Clinical trials

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.

PCOS affects between 5 and 10% of women of reproductive age and can cause increased body hair and acne, irregular menstrual periods, and fertility problems. It is the most common endocrine disorder in women of reproductive age but is still one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause, and anxiety or depression, which can greatly impact the quality of life for women affected by the condition.
April 17, 2023
|

You can now participate in the clinical trial for polycystic ovary syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain!

The clinical trials is aimed at girls and women with Polycystic Ovary Syndrome (PCOS) and who fulfill the following criteria:

✔ 12-24 years

✔ Irregular periods

✔ High amount of body hair

Spiomet4Health aims to provide a novel treatment for adolescent girls and young adult women with Polycystic Ovary Syndrome (PCOS). At ASPHALION, we are proud regulatory partners of this EU-funded HORIZON project. We are committed to improving women’s health!

➥ Come join Spiomet4Health clinicaltrials!

ℹ Further information ⬇

 

You can now participate in the clinical trial for Polycystic Ovary Syndrome (PCOS) in Norway, Denmark, Italy, Austria, Turkey and Spain

Search News & Events

  • Search

  • Filter by category

Share

Related news and events

ARDAT | General Assembly Meeting in Barcelona

May 5, 2025

Last week, ARDAT project members gathered in Barcelona for the project’s General Assembly. The ARDAT project is focused on accelerating the research and development of

EVENT | New European R&I Framework Programme

April 4, 2025

On April 3rd, Asphalion’s Montse Domingo participated in the first working session on the upcoming European Research and Innovation Framework Programme (FP10). The session was

HORIZON Europe Project | PragmaTIL

April 2, 2025

This project emphasizes patient engagement and involvement, ensuring that patient perspectives are integrated into the study design and execution. The focus on reducing treatment toxicity and improving quality of life is at the heart of this research, illustrating a comprehensive approach to patient care and scientific discovery.

More news & Events

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Logo Asphalion
Free Meeting

Services

SDGs

Sustainable Development Goals - Logo

As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.

Memberships & PartnershipS

Catalonia.health
Catalonia Trade & Investment - ACCIÓ
Team PRRC
Veeva Certified Partner
Navarra Health Cluster
Cluster MAD eHealth

Quality Management System

Innovative SME

SDGs

Sustainable Development Goals - Logo

As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.

© Asphalion

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule Now!
Schedule a meeting